INTEGRATED DNA TECHNOLOGIES, INC.

Integrated DNA Technologies, Inc. specializes in the design, synthesis, and production of custom oligonucleotides, synthetic DNA constructs, and molecular reagents for advanced genomic research and diagnostic applications. Their core capabilities include the manufacturing of antisense oligonucleotides, sgRNAs, gBlocks, and CRISPR-Cas9 components, supporting cutting-edge applications in neurodegenerative disease research, high-throughput sequencing, and precision genomics. The company provides highly customized, sequence-specific DNA products with stringent quality controls, enabling researchers to conduct exome sequencing, amplicon genotyping, and in vivo toxicology studies. Their technical expertise spans molecular biology reagent development, scalable GMP-grade synthesis, and rapid turnaround of complex nucleic acid constructs, distinguishing them as a trusted supplier for mission-critical research tools in academic, clinical, and defense laboratories. The contractor maintains a strong and consistent relationship with the Department of Health and Human Services, supplying essential reagents to the NIH Intramural Sequencing Center and other research divisions for large-scale DNA sequencing and functional genomics projects. They also support the Department of Defense with custom oligonucleotide reagents for diagnostic and biothreat detection applications, and have delivered specialized DNA probes to the USDA for marine aquaculture genotyping. These engagements reflect a pattern of serving high-precision, research-driven federal science missions requiring reliability and technical customization. Their primary industry focus lies in in-vitro diagnostic substance manufacturing and basic organic chemical production, positioning them at the intersection of biotechnology and molecular diagnostics. They serve verticals including biomedical research, infectious disease surveillance, and environmental genomics, with a clear emphasis on enabling next-generation sequencing and gene editing workflows. As a privately held entity headquartered in Coralville, Iowa, Integrated DNA Technologies, Inc. operates without federal certifications but maintains a proven track record of delivering specialized, non-commercialized research reagents to U.S. government laboratories. Their geographic presence and technical focus make them a key enabler of federal biodefense and public health research initiatives.